1. Home
  2. AXGN vs AGIO Comparison

AXGN vs AGIO Comparison

Compare AXGN & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$40.84

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.12

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
AGIO
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
AXGN
AGIO
Price
$40.84
$28.12
Analyst Decision
Strong Buy
Buy
Analyst Count
9
8
Target Price
$42.33
$38.88
AVG Volume (30 Days)
1.0M
1.2M
Earning Date
04-28-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$225,208,000.00
$43,011,000.00
Revenue This Year
$20.57
$76.75
Revenue Next Year
$16.68
$170.73
P/E Ratio
N/A
N/A
Revenue Growth
20.21
N/A
52 Week Low
$9.22
$22.24
52 Week High
$45.83
$46.00

Technical Indicators

Market Signals
Indicator
AXGN
AGIO
Relative Strength Index (RSI) 57.20 47.19
Support Level $29.48 $26.61
Resistance Level $45.14 $29.39
Average True Range (ATR) 1.79 1.09
MACD -0.44 0.23
Stochastic Oscillator 23.52 76.38

Price Performance

Historical Comparison
AXGN
AGIO

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: